Pregled bibliografske jedinice broj: 817541
Reporting Vaginal Dose Point in Cervical Cancer Patients Treated with Combined EBRT and HDR Brachytherapy
Reporting Vaginal Dose Point in Cervical Cancer Patients Treated with Combined EBRT and HDR Brachytherapy // Knjiga sažetaka - 9. onkološki kongres s međunarodnim sudjelovanjem
Poreč, Hrvatska, 2016. str. 65-65 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 817541 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Reporting Vaginal Dose Point in Cervical Cancer Patients Treated with Combined EBRT and HDR Brachytherapy
Autori
Gregov, Marin ; Budanec, Mirjana ; Mrčela, Iva ; Mlinarić, Mihaela ; Jakšić, blanka ; Bolanča, Ante ; Kusić, Zvonko ; Frobe, Ana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Knjiga sažetaka - 9. onkološki kongres s međunarodnim sudjelovanjem
/ - , 2016, 65-65
Skup
9. onkološki kongres s međunarodnim sudjelovanjem
Mjesto i datum
Poreč, Hrvatska, 07.04.2016. - 10.04.2016
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
HDR brachytherapy; cervical cancer; vaginal dose
Sažetak
Cervical cancer patients with locally advanced disease are treated with combined external beam radiotherapy EBRT and high dose rate brachytherapy HDRBT. In treatment reports, doses to HRCTV (high risk clinical target volume) and doses for organs at risk, bladder and rectum, are usually reported. Dose constraints for vagina as organ at risk and methods for reporting vaginal dose points are not yet introduced in clinical practice. This study aims to analyze and report vaginal dose points in the lower and upper part of vagina.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Iva Mrčela
(autor)
Ana Fröbe
(autor)
Mirjana Budanec
(autor)
Zvonko Kusić
(autor)
Mihaela Mlinarić
(autor)
Ante Bolanča
(autor)
